← Open Payments lookup

STELLA ADU-GYAMFI: Open Payments

NPI 1033445051 · WORCESTER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$676 in 39 payments from 9 companies in 2025. Trend: 2023 $410 · 2024 $594 · 2025 $676

Food & beverage: $676
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.21$264
Alkermes, Inc.5$151
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$70
E.R. Squibb & Sons, L.L.C.3$66
Lundbeck LLC2$53
Axsome Therapeutics, Inc.1$21
Neurocrine BioSciences, Inc.1$20
Vertical Pharmaceuticals, LLC1$17
Takeda Pharmaceuticals U.S.A., Inc.1$14

Products named: REXULTI, LYBALVI, CAPLYTA, COBENFY, ARISTADA, VIVITROL, Auvelity, INGREZZA.

Industry payments across MA — which companies pay providers there.